FHLC vs XBI: Holdings Overlap
FHLCFidelity MSCI Health Care Index ETF
Fidelity · 337 holdings · $3.3B · as of 2026-04-30
XBIState Street® SPDR® S&P® Biotech ETF
State Street (SPDR) · 149 holdings · $10.0B · as of 2026-08-06
Holdings snapshots are 98 days apart (FHLC: 2026-04-30, XBI: 2026-08-06). Weights and index membership change between snapshots, so the true current overlap is typically higher than shown. For funds tracking the same index, the gap can be 5–15 points.
How similar are FHLC and XBI?
Fidelity MSCI Health Care Index ETF (FHLC, by Fidelity) holds 337 positions; State Street® SPDR® S&P® Biotech ETF (XBI, by State Street (SPDR)) holds 149. They have 116 holdings in common, and by portfolio weight the two funds are 13.2% identical. In practical terms the pair is lightly overlapping, with most of each portfolio distinct.
- Overlap by Weight
- 13.2%Sum of the smaller weight of each shared holding
- Shared Holdings
- 116FHLC holds 337 · XBI holds 149
- Weight in Shared Holdings
- FHLC 22%·XBI 91%Share of each fund's weight in stocks both funds own
Based on each fund's latest official holdings. How is this calculated?
What makes each fund different
Only in FHLC
221 of 337 positions (77.3% of the fund) are not held by XBI. Showing the top 30 by weight.
Only in XBI
33 of 149 positions (8.8% of the fund) are not held by FHLC. Showing the top 30 by weight.
Sector Breakdown
| Sector | FHLC | XBI |
|---|---|---|
| Health Care | 99.6% | 95.5% |
| Other Sectors | 0.0% | 0.0% |
| Unclassified | 0.0% | 4.6% |
Share of each fund's portfolio weight by GICS-style sector, compiled from issuer fund data and our own classification of the holdings, not the issuers' published sector charts. “Unclassified” is weight we could not classify (0% of FHLC, 5% of XBI).
Performance
| Fund | 1M | YTD | 1Y | 3Y (ann.) | 5Y (ann.) | 10Y (ann.) | Yield |
|---|---|---|---|---|---|---|---|
| FHLC | +0.7% | +9.3% | +33.0% | +10.0% | +5.3% | +10.1% | 1.26% |
| XBI | -4.0% | +29.2% | +85.3% | +26.3% | +4.5% | +9.5% | 0.36% |
Total returns including dividends, from adjusted daily closes as of 2026-08-07. 3Y/5Y/10Y are annualized. Yield is trailing-12-month distributions over the last close. Past performance does not predict future results.
Project the growth of $10,000 in FHLC vs XBI →
Shared Holdings(116)
The top 10 shared positions account for 60% of the overlap, led by REGN, AMGN and VRTX.
 REGNRegeneron Pharmaceuticals, Inc. COM | 1.18% | 1.24% | 1.18% |
|---|---|---|---|
 AMGNAmgen Inc. COM | 3.01% | 1.16% | 1.16% |
 VRTXVertex Pharmaceuticals Incorporated COM | 1.75% | 1.07% | 1.07% |
 ABBVAbbVie Inc. COM | 6.03% | 1.05% | 1.05% |
 GILDGilead Sciences Inc. COM | 2.62% | 1.04% | 1.04% |
 ALNYAlnylam Pharmaceuticals Inc. COM | 0.66% | 0.72% | 0.66% |
 INSMInsmed Inc COM PAR $.01 | 0.47% | 1.39% | 0.47% |
 BIIBBiogen Inc COM | 0.45% | 1.03% | 0.45% |
 NTRANatera Inc. COM | 0.44% | 1.18% | 0.44% |
 UTHRUnited Therapeutics Corporation COM | 0.38% | 0.95% | 0.38% |
 RVMDRevolution Medicines Inc COM | 0.38% | 1.33% | 0.38% |
 MRNAModerna Inc COM | 0.26% | 1.13% | 0.26% |
 INCYIncyte Corporation. COM | 0.26% | 1.09% | 0.26% |
 NBIXNeurocrine Biosciences Inc COM | 0.21% | 0.96% | 0.21% |
 IONSIonis Pharmaceuticals, Inc. COM | 0.19% | 0.72% | 0.19% |
 EXELExelixis, Inc. COM | 0.18% | 0.96% | 0.18% |
 ROIVRoivant Sciences Ltd SHS | 0.17% | 1.19% | 0.17% |
 BBIOBridgebio Pharma Inc COM | 0.17% | 1.19% | 0.17% |
 BMRNBiomarin Pharmaceutical Inc. COM | 0.16% | 1.06% | 0.16% |
 ARWRArrowhead Pharmaceuticals Inc COM | 0.15% | 1.17% | 0.15% |
 MDGLMadrigal Pharmaceuticals Inc COM | 0.12% | 1.05% | 0.12% |
 HALOHalozyme Therapeutics Inc COM | 0.12% | 1.18% | 0.12% |
 PRAXPraxis Precision Medicines Inc COM NEW | 0.12% | 1.49% | 0.12% |
 CYTKCytokinetics Incorporated | 0.12% | 1.17% | 0.12% |
 PCVXVaxcyte Inc COM | 0.11% | 1.25% | 0.11% |
Frequently Asked Questions
How much do FHLC and XBI overlap?
FHLC and XBI overlap by 13.2% of portfolio weight. They share 116 holdings (FHLC holds 337 positions and XBI holds 149), based on each fund's latest SEC-reported holdings.
Is it redundant to own both FHLC and XBI?
The two portfolios are 13.2% identical by weight. Owning both is not redundant. Most of each portfolio is distinct, so the funds can serve different roles.
What are the biggest shared holdings of FHLC and XBI?
The largest positions held by both funds are REGN, AMGN, VRTX, ABBV and GILD. Together the top 10 shared positions account for 60% of the total overlap.
What does FHLC own that XBI doesn't?
221 positions (77.3% of FHLC) are unique to FHLC, led by LLY, JNJ and UNH. In the other direction, 33 positions (8.8% of XBI) are unique to XBI.